Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation

Published:2017-02-27 Issue:2 Volume:12 Page:e0171674
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jhun JooYeon,Kwon Jeong-Eun,Kim Se-Young,Jeong Jeong-Hee,Na Hyun Sik,Kim Eun-Kyung,Lee Seung Hoon,Jung KyungAh,Min Jun-Ki,Cho Mi-La

Funder

Ministry for Health & Welfare

National Research Foundation of Korea

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. CD4+ T cells in atherosclerosis;X Zhou;Biomed Pharmacother,2003

2. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque;L Jonasson;Arteriosclerosis,1986

3. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice;X Zhou;Circulation,2000

4. Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets;C Lahoute;Nat Rev Cardiol,2011

5. Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells;P Ponnuswamy;Vascul Pharmacol,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological therapy targeting the immune response in atherosclerosis;International Immunopharmacology;2024-11

2. Low-grade inflammation in the post-COVID period as a strategic goal of treatment and rehabilitation;Acta Biomedica Scientifica;2024-05-30

3. Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review;Terapevticheskii arkhiv;2023-01-16

4. Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes;PLOS ONE;2022-12-27

5. Gastroprotectant Rebamipide: review of action mechanisms and clinical applications;Glavvrač (Chief Medical Officer);2022-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3